Feedback / Questions
docetaxel - Generic mfg.
AB-16B5 - Alethia BioTherap
http://www.globenewswire.com/news-release/2020/05/21/2036916/0/en/Alethia-Biotherapeutics-Announces-Receipt-of-FDA-Authorization-to-Begin-Phase-2-Development-for-its-EMT-Inhibitor-AB-16B5.html
May 21, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next